Women and elderly: Subgroups under-represented in clinical trials

Current Opinion in Cardiology

Volumn 25, Issue 4, 2010, Pages 335-339

  Devlin, Gerard ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

elderly; heart failure; ischaemic heart disease; women

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRASUGREL; TICAGRELOR;

ACUTE HEART INFARCTION; AGED; BLEEDING; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DEFIBRILLATOR; EVIDENCE BASED MEDICINE; FEMALE; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYMPTOM;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; GERIATRIC ASSESSMENT; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PATIENT CARE; RISK FACTORS; WOMEN'S HEALTH;

EID: 77953808537     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328338bcab     Document Type: Review

References (32)

1. Canto JG, Goldberg RJ, Hand MM, et al. Symptom presentation of women with acute coronary syndromes: myth vs. reality. Arch Intern Med 2007; 167:2405-2413.
2. Smith-Bindman R, Lipson J, Marcus R, et al. Radiation dose associated with common computer tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 2009; 169:2078-2086.
3. Shaw LJ, Shaw RE, Bairey Merz CN, et al. Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology: National Cardiovascular Data Registry (ACC-NCDR). Circulation 2008; 117:1787- 1801.
4. Zethelius B, Berglund L, Sundstrom J, et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008; 358:2107-2116.
5. Arant CB, Wessel TR, Ridker PM, et al. Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: a report from the NHLBI-sponsored WISE study. Clin Cardiol 2009; 32:244-250.
6. Anand SS, Islam S, Rosengren A, et al., on behalf of the INTERHEART Investigators. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J 2008; 29:932-940.
7. Anderson RD, Pepine CJ. Gender differences in the treatment of acute myocardial infarction: bias or biology? Circulation 2007; 115:823-826.
8. Brugts JJ, Yetgin T, Hoeks SE, et al. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: metaanalysis of randomised controlled trials. BMJ 2009; 338:b2376.
9. Ridker PM, Danielson E, Fonseca FAH, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359:2195-2207.
10. The Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke and mortality: an individual participant meta-analysis. Lancet 2010; 375: 132-140.
11. Dey S, Flather MD, Devlin G, et al., for the GRACE investigators. Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart 2009; 95:20-26.
12. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and theSociety of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007; 50:e1-e157.
13. O'Donoghue M, BodenWE, Braunwald E, et al. Early invasive vs. conservative treatment strategies in women and men with unstable angina and non-STsegment elevation myocardial infarction: a metaanalysis. J Am Med Assoc 2008; 300:71-80.
14. Akhter N, Milford-Beland, Roe MT, et al. Gender differences among patients with acute coronary syndromes undergoing percutaneous intervention in the American College of Cardiology: National Cardiovascular Data Registry (ACC-NCDR). Am Heart J 2009; 157:141-148
15. Berger JS, Bhatt DL, Cannon CP, et al. The relative efficacy and safety of clopidogrel in women and men. A sex-specific collaborative meta-analysis. J Am Coll Cardiol 2009; 54:1935-1945.
16. Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373:1849-1860.
17. BodenWE,O'Rourke RA, Teo KK, et al. Optimalmedical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356:1503-1516.
18. Bugiardini R, Manfrini O, Pizzi C, et al. Endothelial function predicts future development of coronary artery disease. A study on women with chest pain and normal angiograms. Circulation 2004; 109:2518-2523.
19. Hsich EM, Pina IL. Heart failure in women. A need for prospective data. J Am Coll Cardiol 2009; 54:491-498.
20. Ghanbari H, Dalloul G, Hasan R, et al. Effectiveness of implantable cardioverter- defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch Intern Med 2009; 169:1500-1506.
21. Afilalo J, Duque G, Steele R, et al. Statins for secondary prevention in elderly patients: a hierarchical Bayesian meta-analysis. J Am Coll Cardiol 2008; 51:37-45.
22. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358:1887-1898.
23. Devlin G, Gore J, Elliott J, et al. Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes. The Global Registry of Acute Coronary Events. Eur Heart J 2008; 29:1275-1282.
24. Hlatky MA, Boothroyd DB, Bravata DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 2009; 373:1190-1197.
25. Shroyer L, Grover F, Hattler B, et al. On-pump versus off-pump coronaryartery bypass surgery. N Engl J Med 2009; 361:1827-1837.
26. Schiele F, Meneveau N, Seronde MF, et al., on behalf of the 'Reseau de Cardiologie de Franche Comte'. Changes in management of elderly patients with myocardial infarction. Eur Heart J 2009; 30:987-994.
27. Setoguchi S, Glynn RJ, Avorn J, et al. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge. A 10-year trend analysis. J Am Coll Cardiol 2008; 51: 1247-1254.
28. Flather MD, Shibata MC, Coats AJS, et al. Randomised trial to determine the effect of nebivolol on mortality and hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005; 26:215-225.
29. van Veldhuisen DJ, Cohen-Solal A, Bohm M, et al. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). J Am Coll Cardiol 2009; 53:2150-2158.
30. Komajda M, Hanon O, Hochadel M, et al. Contemporary management of octogenarians hospitalized for heart failure in Europe: EuroHeart Failure Survey II. Eur Heart J 2009; 30:478-486.
31. Pfisterer M, Buser P, Rickli H, et al. BNP-guided v symptom-guided heart failure therapy: The Trial of Intensified vs. Standard Medical Therapy in Elderly Patients with Congestive Cardiac Failure (TIME-CHF) randomised trial. J Am Med Assoc 2009; 301:388-392.
32. Hernandez AF, Fonarow GC, Hammill BG, et al. Clinical effectiveness of implantable cardioverter-defibrillators among Medicare beneficiaries with heart failure. Circ Heart Fail 2010; 3:7-13.